Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia

被引:7
作者
Bouhafs, RKL [1 ]
Jarstrand, C
Robertson, B
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol, Div Clin Bacteriol, Stockholm, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Microbiol, Stockholm, Sweden
[3] Karolinska Inst, Dept Woman & Child Hlth, Div Expt Perinatal Pathol, Stockholm, Sweden
关键词
surfactant; lipid peroxidation; group B streptococci (GBS);
D O I
10.1007/s00408-003-1027-9
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Group B streptococcal (GBS) pneumonia, with neutrophilic granulocytes immigrating into the lungs, may occur in neonates. The incidence is particularly high among preterm infants, who often are treated with exogenous surfactant. We have previously demonstrated in vitro that neutrophils stimulated by GBS cause lipid peroxidation (LPO) and functional impairment of lung surfactant. The present study aimed at evaluating LPO of exogenous lung surfactant (Curosurf) and the protective effect of the natural antioxidant, vitamin E in immature ventilated newborn rabbits with experimental neonatal GBS pneumonia. There was a prominent proliferation of GBS in the lungs of animals treated with surfactant and ventilated for 5 h. GBS-infected rabbits had a higher LPO of lung lavage fluid than non-infected ones. The LPO could be diminished using vitamin E, which, however, did not affect bacterial proliferation. During the 5-h incubation period, mean lung-thorax compliance values were significantly lower in GBS-infected than in noninfected animals. We speculate that addition of vitamin E to exogenous surfactant preparations may improve their resistance to LPO and make them more suitable for treatment of neonates with pneumonia.
引用
收藏
页码:61 / 72
页数:12
相关论文
共 39 条
[1]   COMPARISON OF EARLY-ONSET GROUP-B-STREPTOCOCCAL NEONATAL INFECTION AND RESPIRATORY-DISTRESS SYNDROME OF NEWBORN [J].
ABLOW, RC ;
DRISCOLL, SG ;
EFFMANN, EL ;
GROSS, I ;
JOLLES, CJ ;
UAUY, R ;
WARSHAW, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (02) :65-70
[2]  
ALENGHAT E, 1984, PEDIATRICS, V74, P221
[3]  
AUTEN RL, 1991, PEDIATRICS, V87, P101
[4]  
Baker C.J., 1995, INFECT DIS FETUS NEW, V37, P980
[5]   Lipid peroxidation of lung surfactant by bacteria [J].
Bouhafs, RKL ;
Jarstrand, C .
LUNG, 1999, 177 (02) :101-110
[6]  
Bouhafs RKL, 1999, PEDIATR PULM, V27, P322, DOI 10.1002/(SICI)1099-0496(199905)27:5<322::AID-PPUL5>3.0.CO
[7]  
2-E
[8]   Direct and phagocyte-mediated lipid peroxidation of lung surfactant by group B streptococci [J].
Bouhafs, RKL ;
Rauprich, P ;
Herting, E ;
Schröder, A ;
Robertson, B ;
Jarstrand, C .
LUNG, 2000, 178 (05) :317-329
[9]  
Bouhafs RKL, 2000, PEDIATR PULM, V30, P106, DOI 10.1002/1099-0496(200008)30:2<106::AID-PPUL5>3.0.CO
[10]  
2-4